NGNE

Neurogene Inc (NGNE)

US
$ 00%

Price Chart

Key Statistics

Market Cap
$ 283.58M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
0
52W High
$ 74.49
52W Low
$ 6.88
Dividend Yield
0.00%
Beta
0.00

Technicals

50-Day MA
20.4263
200-Day MA
18.7007
52 Week High
74.49
52 Week Low
6.875

About NGNE

Neurogene Inc., a clinical stage biotechnology company, develops genetic medicines for rare neurological diseases.

Employees
107
Headquarters
New York, NY
CEO
Dr. Rachel L. McMinn Ph.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg